Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.
about
New treatment options for alcoholic hepatitisPhase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients.DNA aptamers as molecular probes for colorectal cancer study.Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.Celecoxib pre-treatment in human colorectal adenocarcinoma patients is associated with gene expression alterations suggestive of diminished cellular proliferationMeta-analysis comparing maintenance strategies with continuous therapy and complete chemotherapy-free interval strategies in the treatment of metastatic colorectal cancer.Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients.In vivo optical molecular imaging of matrix metalloproteinase activity following celecoxib therapy for colorectal cancer.Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer.
P2860
Q26751402-456E1383-4E46-4731-9CD7-7BD0F2BFFF10Q33395587-D4642624-40DF-4616-969C-057B47304C21Q33775559-A23DE50A-CAF6-4F0B-A055-CADA2F7AFF81Q36172737-441EC397-A47F-42E7-9530-B9C810D433DFQ36935231-8E559EEF-4C6F-47B5-87FE-1D37C157AC58Q37362955-25AB678E-08E4-4FBF-B401-B7FDF5681577Q37771244-2DB62729-9CB6-4EB5-A00A-46821D76D844Q41836058-001AEF7A-29C2-4190-9D00-605911764B30Q53748154-AD0E8D64-F909-4096-BBDE-28A3186CE290
P2860
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Phase II study of an optimized ...... rectal cancer: a GERCOR study.
@ast
Phase II study of an optimized ...... rectal cancer: a GERCOR study.
@en
type
label
Phase II study of an optimized ...... rectal cancer: a GERCOR study.
@ast
Phase II study of an optimized ...... rectal cancer: a GERCOR study.
@en
prefLabel
Phase II study of an optimized ...... rectal cancer: a GERCOR study.
@ast
Phase II study of an optimized ...... rectal cancer: a GERCOR study.
@en
P2093
P356
P1433
P1476
Phase II study of an optimized ...... orectal cancer: a GERCOR study
@en
P2093
A de Gramont
C Tournigand
GERCOR (French Oncology Research Group)
R Fellague-Chebra
S Postel Vinay
P356
10.1093/ANNONC/MDL336
P577
2006-10-09T00:00:00Z